Statistics for Checkpoint Therapeutics (id:5919 CKPT)

Valuation metrics

Market cap

169.45M

Enterprise value

150.36M

Trailing P/E (ttm)

-1.18

Forward P/E

-19.28

PEG ratio

-19.28

Price/Sales (ttm)

2.17K

Price/Book (mrq)

-12.85

Enterprise Value/Revenue

1.93K

Enterprise Value/EBITDA

-2.87

Overview

Shares outstanding

48.13M

Float

34.79M

Shares short

5.56M

% Held by insiders

0.16%

% Held by institutions

0.14%

Average volume (10 days)

759.22K

Average volume (90 days)

Price summary

52-Week low

1.36

52-Week high

3.97

52-Week change

41.60%

Beta

1.24

50-Day moving average

2.89

200-Day moving average

2.23

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

December 06th, 2022

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-16,275.61%

Operational effectiveness

Return on assets

-316.70%

Return on equity

397.39%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

0.00

Net income to common (ttm)

-42,467,000.00

Diluted EPS (ttm)

-1.83

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

4.95M

Total cash per share (mrq)

0.11

Total debt (mrq)

0.00

Total Debt/Equity (mrq)

0.00

Current ratio (mrq)

26.50%

Book value per share (mrq)

-0.47

Cash flow

Cash flow statement

-34,297,000.00

Levered free cash flow (LFCF)

-28,931,876.00